ERYTECH announces publication of two articles describing clinical results with eryaspase/GRASPA Post author:admERY Post published:October 20, 2015 Post category:Newsroom ERYTECH announces the publication of two peer-reviewed manuscripts describing clinical results obtained with eryaspase/GRASPA®. You Might Also Like ERYTECH receives Orphan Drug Designation by the FDA for eryaspase in Acute Myeloid Leukemia April 2, 2014 ERYTECH Announces the Hosting of a KOL Event as the TRYbeCA-1 Phase 3 Trial in Second-line Pancreatic Cancer Nears Complete Enrollment September 14, 2020 ERYTECH appoints new independent board member March 26, 2015
ERYTECH receives Orphan Drug Designation by the FDA for eryaspase in Acute Myeloid Leukemia April 2, 2014
ERYTECH Announces the Hosting of a KOL Event as the TRYbeCA-1 Phase 3 Trial in Second-line Pancreatic Cancer Nears Complete Enrollment September 14, 2020